Description
SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analog of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.SDB-005 sales
The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006. This compound is a potent agonist of the CB1 receptor (Ki = 21 nM) and CB2 receptor (Ki = 140 nM).
While the properties of this compound are not known, the addition of fluorine to the terminal carbon of the alkyl chain in similar cannabimimetic compounds typically increases affinity for both CB receptors significantly.SDB-005 sales
This product is intended for research and forensic applications. HU-211
